TSC2 GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited    
TSC2 Gene Panel by NGS is a specialized genetic test that detects mutations in the TSC2 gene, which are associated with Tuberous Sclerosis Complex (TSC), a multisystem disorder causing benign tumor growth in various organs. This test helps in confirming the clinical diagnosis, evaluating the severity of disease, and guiding management and family counseling. It is especially useful in individuals presenting with seizures, developmental delay, skin lesions, kidney angiomyolipomas, or cardiac rhabdomyomas. Early genetic detection enables timely treatment and monitoring to prevent complications

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 17,850.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: G0153

Frequently Asked Questions (FAQ's):

What is the purpose of the TSC2 Gene Panel test?
This test identifies genetic mutations in the TSC2 gene to confirm Tuberous Sclerosis Complex and assess risk for disease-related complications.

Who should consider this test?
Individuals with symptoms such as recurrent seizures, cognitive impairment, skin manifestations, or tumors in the brain, kidneys, lungs, or heart should undergo this test.

What sample type is required?
An EDTA blood sample is required for Next Generation Sequencing (NGS).

How long does the report take?
Results typically take around 2–4 weeks, depending on laboratory workflow.

Can this test help in treatment or prognosis?
Yes, identifying the mutation supports clinical decision-making, targeted therapies (like mTOR inhibitors), and genetic counseling for family planning.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab